The future of Genetic Engineering: Next-Generation Sequencing technology

In 1977, Frederick Sanger and colleagues revolutionised the world of genetics by developing a DNA sequencing method called Sanger sequencing. This method is considered the gold standard for DNA sequencing, and it ruled the world for almost 40 years before next-generation sequencing (NGS) was developed. Sanger sequencing is time-consuming, gives less high-throughput, and is more cost-effective than next-generation sequencing, but it remains valuable for verifying sequences and smaller-scale projects in molecular biology. While NGS is rapid and gives high-throughput sequencing of DNA and RNA molecules, NGS has paved the way for breakthroughs in various scientific disciplines, from genetics and personalised medicine to evolutionary biology and microbiology. NGS emerged in the mid-2000s, featuring massively parallel sequencing, which allowed for the simultaneous sequencing of millions of DNA fragments. NGS platforms have dramatically increased sequencing speed and reduced costs, making genomics research more accessible.

Principles of NGS

To prepare for DNA library preparation, DNA or RNA samples are fragmented into smaller pieces. Adapters are ligated to the ends of the fragments to enable sequencing. The DNA fragments are immobilised on a solid surface, and PCR amplification generates multiple copies of the DNA fragments. During sequencing, the nucleotide sequence is determined as individual bases (A, T, C, and G) are added, which are fluorescently labelled and are incorporated into the growing DNA strand. Images of the fluorescently labelled nucleotides are captured at each cycle of sequencing. Software processes the images, translating fluorescence signals into DNA base calls and creating a sequencing read. The resulting sequencing data are aligned to a reference genome or assembled de novo for genome or transcriptome analysis. Bioinformatics tools are used to identify genetic variants, assess gene expression levels, or analyse epigenetic modifications, depending on the research objectives.

https://www.istockphoto.com/vector/genome-sequencing-nfortaphic-human-genome-project-flat-style-vector-illustration-gm1055935082-282186722?phrase=next-generation+sequencing

Applications of NGS

Genome sequencing: NGS has made whole-genome sequencing (WGS) of organisms more efficient, enabling the study of genetic variations, evolution, and comparative genomics.

Transcriptomics: RNA-Seq allows for the quantification of gene expression levels, alternative splicing, and non-coding RNA analysis.

Epigenomics: Techniques like ChIP-Seq and bisulfite sequencing reveal epigenetic modifications, such as DNA methylation and histone marks.

Metagenomics: NGS is used to study complex microbial communities in environments like the human gut, oceans, and soil. NGS identifies cancer-associated mutations, aiding in diagnosis, prognosis, and targeted therapy development.

Personalized medicine: Genetic testing and pharmacogenomics use NGS to tailor medical treatments to an individual's genetic makeup.

Advancements in NGS

• Single-molecule sequencing technologies (e.g., PacBio and Oxford Nanopore) offer long reads, reducing assembly challenges.
• Advances in NGS chemistry and workflows continue to drive down the cost of sequencing, democratising genomics research.
• NGS platforms can now generate billions of reads per run, allowing for deeper sequencing coverage.
• Improvements in error correction algorithms have enhanced the precision and accuracy of NGS data.

Third-generation sequencing technologies are poised to provide even longer reads, improving genome assembly and structural variant detection. Single-cell RNA-Seq and DNA-Seq are opening new frontiers in understanding cellular heterogeneity and rare cell populations. NGS is becoming increasingly integrated into clinical practice for diagnostics, disease monitoring, and treatment decisions.

Managing and analysing vast NGS datasets requires robust computational infrastructure and bioinformatics expertise. De novo assembly of genomes from short-read NGS data can be challenging for highly repetitive regions. Despite improvements, NGS technologies can still produce errors, especially in homopolymeric regions. The ease of generating genetic data raises ethical issues related to privacy, consent, and data security.

Next-generation sequencing technology has catalysed a genomics revolution, driving innovation and discoveries across a spectrum of scientific disciplines. From decoding genomes to unravelling the complexities of gene expression, NGS has become an indispensable tool for researchers and clinicians alike. As NGS continues to evolve and become more accessible, it holds immense promise for advancing our understanding of biology, medicine, and the environment, ultimately shaping the future of science and healthcare.

MD: NGS is an advanced genomic technology that has revolutionized the field of genetic research. This article provides a brief review of NGS technology, its applications, and its advancements.